Advertisement
Screener

CENCORA, INC. (COR) Proceeds from Lines of Credit

2.6 / 5 stars · 59/115 Roast Me

CENCORA, INC. Proceeds from Lines of Credit

CENCORA, INC. (COR) reported Proceeds from Lines of Credit of $83.89 billion for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-05

  • CENCORA, INC. proceeds from lines of credit for the quarter ending 2026-06-30 was $12.88B, a 69.70% decline year-over-year.
  • CENCORA, INC. proceeds from lines of credit for the quarter ending 2026-03-31 was $47.21B, a 67.56% increase year-over-year.
  • CENCORA, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $23.79B, a 53.95% increase year-over-year.
  • CENCORA, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $45.98B, a 253.16% increase year-over-year.
  • CENCORA, INC. proceeds from lines of credit for fiscal 2022 was $4.83B, a 2.74% decline from fiscal 2021.
  • CENCORA, INC. proceeds from lines of credit for fiscal 2021 was $4.97B, a 4148.81% increase from fiscal 2020.
  • CENCORA, INC. proceeds from lines of credit for fiscal 2020 was $116.95M.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2026-06-30$12.88B
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-05
$60.10B
derived: sum of 2 quarters · filed 2026-08-05
$83.89B
10-Q · filed 2026-08-05
$129.87B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$47.21B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-06
$71.00B
10-Q · filed 2026-05-06
$116.99B
derived: sum of 3 quarters · filed 2026-05-06
$159.51B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$23.79B
10-Q · filed 2026-02-04
$69.77B
derived: sum of 2 quarters · filed 2026-02-10
$112.29B
derived: sum of 3 quarters · filed 2026-08-05
$140.47B
derived: sum of 4 quarters · filed 2026-08-05
2025-09-30$45.98B
derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10
$88.50B
derived: sum of 2 quarters · filed 2026-08-05
$116.68B
derived: sum of 3 quarters · filed 2026-08-05
$132.13B
8-K · filed 2026-02-10
2025-06-30$42.52B
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-05
$70.70B
derived: sum of 2 quarters · filed 2026-08-05
$86.15B
10-Q · filed 2026-08-05
$99.17B
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$28.18B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-06
$43.63B
10-Q · filed 2026-05-06
$56.65B
derived: sum of 3 quarters · filed 2026-05-06
$65.40B
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$15.45B
10-Q · filed 2026-02-04
$28.47B
derived: sum of 2 quarters · filed 2026-02-10
$37.22B
derived: sum of 3 quarters · filed 2026-02-10
$73.99B
derived: sum of 4 quarters · filed 2026-02-10
2024-09-30$13.02B
derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10
$21.77B
derived: sum of 2 quarters · filed 2026-02-10
$58.53B
derived: sum of 3 quarters · filed 2026-02-10
$69.70B
8-K · filed 2026-02-10
2024-06-30$8.75B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-06
$45.51B
derived: sum of 2 quarters · filed 2025-08-06
$56.68B
10-Q · filed 2025-08-06
$85.09B
derived: sum of 4 quarters · filed 2026-02-10
2024-03-31$36.76B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-07
$47.94B
10-Q · filed 2025-05-07
$76.34B
derived: sum of 3 quarters · filed 2026-02-10
$90.37B
derived: sum of 4 quarters · filed 2026-02-10
2023-12-31$11.17B
10-Q · filed 2025-02-05
$39.58B
derived: sum of 2 quarters · filed 2026-02-10
$53.61B
derived: sum of 3 quarters · filed 2026-02-10
$87.51B
derived: sum of 4 quarters · filed 2026-02-10
2023-09-30$28.41B
derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10
$42.43B
derived: sum of 2 quarters · filed 2026-02-10
$76.34B
derived: sum of 3 quarters · filed 2026-02-10
$78.22B
8-K · filed 2026-02-10
2023-06-30$14.03B
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-31
$47.93B
derived: sum of 2 quarters · filed 2024-07-31
$49.81B
10-Q · filed 2024-07-31
$50.32B
derived: sum of 4 quarters · filed 2024-11-26
2023-03-31$33.90B
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-01
$35.78B
10-Q · filed 2024-05-01
$36.29B
derived: sum of 3 quarters · filed 2024-11-26
$36.76B
derived: sum of 4 quarters · filed 2024-11-26
2022-12-31$1.88B
10-Q · filed 2024-01-31
$2.39B
derived: sum of 2 quarters · filed 2024-11-26
$2.86B
derived: sum of 3 quarters · filed 2024-11-26
$5.76B
derived: sum of 4 quarters · filed 2024-11-26
2022-09-30$508.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26
$976.76M
derived: sum of 2 quarters · filed 2024-11-26
$3.88B
derived: sum of 3 quarters · filed 2024-11-26
$4.83B
10-K · filed 2024-11-26
2022-06-30$468.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-02
$3.37B
derived: sum of 2 quarters · filed 2023-08-02
$4.32B
10-Q · filed 2023-08-02
$4.67B
derived: sum of 4 quarters · filed 2023-11-21
2022-03-31$2.90B
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02
$3.86B
10-Q · filed 2023-05-02
$4.21B
derived: sum of 3 quarters · filed 2023-11-21
$8.79B
derived: sum of 4 quarters · filed 2023-11-21
2021-12-31$956.83M
10-Q · filed 2023-02-01
$1.31B
derived: sum of 2 quarters · filed 2023-11-21
$5.89B
derived: sum of 3 quarters · filed 2023-11-21
$5.93B
derived: sum of 4 quarters · filed 2023-11-21
2021-09-30$350.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21
$4.93B
derived: sum of 2 quarters · filed 2023-11-21
$4.97B
derived: sum of 3 quarters · filed 2023-11-21
$4.97B
10-K · filed 2023-11-21
2021-06-30$4.58B
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-03
$4.62B
derived: sum of 2 quarters · filed 2022-08-03
$4.62B
10-Q · filed 2022-08-03
$4.62B
derived: sum of 4 quarters · filed 2022-11-22
2021-03-31$39.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-04
$39.08M
10-Q · filed 2022-05-04
$39.08M
derived: sum of 3 quarters · filed 2022-11-22
$68.08M
derived: sum of 4 quarters · filed 2022-11-22
2020-12-31$0.00
10-Q · filed 2022-02-02
$0.00
derived: sum of 2 quarters · filed 2022-11-22
$28.99M
derived: sum of 3 quarters · filed 2022-11-22
$66.36M
derived: sum of 4 quarters · filed 2022-11-22
2020-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22
$28.99M
derived: sum of 2 quarters · filed 2022-11-22
$66.36M
derived: sum of 3 quarters · filed 2022-11-22
$116.95M
10-K · filed 2022-11-22
2020-06-30$28.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-04
$66.36M
derived: sum of 2 quarters · filed 2021-08-04
$116.95M
10-Q · filed 2021-08-04
2020-03-31$37.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-05
$87.95M
10-Q · filed 2021-05-05
2019-12-31$50.58M
10-Q · filed 2021-02-04
2019-06-30$66.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05
$510.37M
derived: sum of 2 quarters · filed 2020-08-05
$607.82M
10-Q · filed 2020-08-05
2019-03-31$443.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07
$541.07M
10-Q · filed 2020-05-07
2018-12-31$97.45M
10-Q · filed 2020-01-30
2018-06-30$92.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-01
$21.95B
derived: sum of 2 quarters · filed 2019-08-01
$24.52B
10-Q · filed 2019-08-01
2018-03-31$21.85B
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-02
$24.43B
10-Q · filed 2019-05-02
2017-12-31$2.58B
10-Q · filed 2019-01-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B